119 related articles for article (PubMed ID: 15774845)
1. Porin A-specific antibody avidity in patients who are convalescing from meningococcal B disease.
Vermont CL; van Dijken HH; de Groot R; van den Dobbelsteen GP
Pediatr Res; 2005 Jul; 58(1):149-52. PubMed ID: 15774845
[TBL] [Abstract][Full Text] [Related]
2. PorA-specific differences in antibody avidity after vaccination with a hexavalent Men B outer membrane vesicle vaccine in toddlers and school children.
Vermont CL; Van Dijken HH; De Groot R; Van Alphen L; Van Den Dobbelsteen GP
Vaccine; 2004 Aug; 22(23-24):3008-13. PubMed ID: 15297049
[TBL] [Abstract][Full Text] [Related]
3. Antibody avidity and immunoglobulin G isotype distribution following immunization with a monovalent meningococcal B outer membrane vesicle vaccine.
Vermont CL; van Dijken HH; van Limpt CJ; de Groot R; van Alphen L; van Den Dobbelsteen GP
Infect Immun; 2002 Feb; 70(2):584-90. PubMed ID: 11796586
[TBL] [Abstract][Full Text] [Related]
4. New zealand epidemic strain meningococcal B outer membrane vesicle vaccine in children aged 16-24 months.
Wong S; Lennon D; Jackson C; Stewart J; Reid S; Crengle S; Tilman S; Aaberge I; O'Hallahan J; Oster P; Mulholland K; Martin D
Pediatr Infect Dis J; 2007 Apr; 26(4):345-50. PubMed ID: 17414400
[TBL] [Abstract][Full Text] [Related]
5. Cross-reactivity of antibodies against PorA after vaccination with a meningococcal B outer membrane vesicle vaccine.
Vermont CL; van Dijken HH; Kuipers AJ; van Limpt CJ; Keijzers WC; van der Ende A; de Groot R; van Alphen L; van den Dobbelsteen GP
Infect Immun; 2003 Apr; 71(4):1650-5. PubMed ID: 12654777
[TBL] [Abstract][Full Text] [Related]
6. Murine monoclonal antibodies to PorA of Neisseria meningitidis show reduced protective activity in vivo against B:15:P1.7,16 subtype variants in an infant rat infection model.
Toropainen M; Saarinen L; van der Ley P; Kuipers B; Käyhty H
Microb Pathog; 2001 Mar; 30(3):139-48. PubMed ID: 11273739
[TBL] [Abstract][Full Text] [Related]
7. Heterologous prime-boost strategy to overcome weak immunogenicity of two serosubtypes in hexavalent Neisseria meningitidis outer membrane vesicle vaccine.
Luijkx T; van Dijken H; van Els C; van den Dobbelsteen G
Vaccine; 2006 Mar; 24(10):1569-77. PubMed ID: 16298029
[TBL] [Abstract][Full Text] [Related]
8. Antibodies to meningococcal class 1 outer-membrane protein and its variable regions in patients with systemic meningococcal disease.
Idänpään-Heikkilä I; Høiby EA; Chattopadhyay P; Airaksinen U; Michaelsen TM; Wedege E
J Med Microbiol; 1995 Nov; 43(5):335-43. PubMed ID: 7562997
[TBL] [Abstract][Full Text] [Related]
9. Understanding the immune responses to the meningococcal strain-specific vaccine MeNZB measured in studies of infants.
Ruijne N; Lea RA; O'Hallahan J; Oster P; Martin D
Clin Vaccine Immunol; 2006 Jul; 13(7):797-801. PubMed ID: 16829618
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of an Anti-meningococcal subtype P1.4 PorA antibody provides basis for peptide-vaccine design.
Oomen CJ; Hoogerhout P; Kuipers B; Vidarsson G; van Alphen L; Gros P
J Mol Biol; 2005 Sep; 351(5):1070-80. PubMed ID: 16038932
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant can improve protection induced by OMV vaccine against Neisseria meningitidis serogroups B/C in neonatal mice.
Fukasawa LO; Dias WO; Schenkman RP; Raw I; Tanizaki MM
FEMS Immunol Med Microbiol; 2004 Jul; 41(3):205-10. PubMed ID: 15196569
[TBL] [Abstract][Full Text] [Related]
12. IgG antibody levels to meningococcal porins in patient sera: comparison of immunoblotting and ELISA measurements.
Wedege E; Bolstad K; Wetzler LM; Guttormsen H
J Immunol Methods; 2000 Oct; 244(1-2):9-15. PubMed ID: 11033014
[TBL] [Abstract][Full Text] [Related]
13. Human B- and T-cell responses after immunization with a hexavalent PorA meningococcal outer membrane vesicle vaccine.
van der Voort ER; van Dijken H; Kuipers B; van der Biezen J; van der Ley P; Meylis J; Claassen I; Poolman J
Infect Immun; 1997 Dec; 65(12):5184-90. PubMed ID: 9393814
[TBL] [Abstract][Full Text] [Related]
14. Passive protection in the infant rat protection assay by sera taken before and after vaccination of teenagers with serogroup B meningococcal outer membrane vesicle vaccines.
Toropainen M; Saarinen L; Wedege E; Bolstad K; Mäkelä PH; Käyhty H
Vaccine; 2005 Sep; 23(40):4821-33. PubMed ID: 15970361
[TBL] [Abstract][Full Text] [Related]
15. Avidity of IgG antibodies against meningococcal serogroup a polysaccharide and correlations with bactericidal activity in sera from meningitis patients and controls from Ethiopia.
Medhane M; Tunheim G; Naess LM; Mihret W; Bedru A; Norheim G; Petros B; Aseffa A; Rosenqvist E
Scand J Immunol; 2014 Apr; 79(4):267-75. PubMed ID: 24383864
[TBL] [Abstract][Full Text] [Related]
16. Development and characterisation of outer membrane vesicle vaccines against serogroup A Neisseria meningitidis.
Norheim G; Aase A; Caugant DA; Høiby EA; Fritzsønn E; Tangen T; Kristiansen P; Heggelund U; Rosenqvist E
Vaccine; 2005 May; 23(29):3762-74. PubMed ID: 15893613
[TBL] [Abstract][Full Text] [Related]
17. Avidity of serogroup A meningococcal IgG antibodies after immunization with different doses of a tetravalent A/C/Y/W135 polysaccharide vaccine.
Bårnes GK; Naess LM; Rosenqvist E; Guerin PJ; Caugant DA;
Scand J Immunol; 2011 Jul; 74(1):87-94. PubMed ID: 21332570
[TBL] [Abstract][Full Text] [Related]
18. Differential capacities of outer membrane proteins from Neisseria meningitidis B to prime the murine immune system after vaccination.
Silva Junior FC; Gioia CA; Oliveira JM; Cruz SC; Frasch CE; Milagres LG
Scand J Immunol; 2007 Jan; 65(1):1-7. PubMed ID: 17212760
[TBL] [Abstract][Full Text] [Related]
19. Stability of PorA during a meningococcal disease epidemic.
Devoy AF; Dyet KH; Martin DR
J Clin Microbiol; 2005 Feb; 43(2):832-7. PubMed ID: 15695688
[TBL] [Abstract][Full Text] [Related]
20. Specificity of bactericidal antibody response to serogroup B meningococcal strains in Brazilian children after immunization with an outer membrane vaccine.
Milagres LG; Gorla MC; Sacchi CT; Rodrigues MM
Infect Immun; 1998 Oct; 66(10):4755-61. PubMed ID: 9746575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
